Dr. Colm Henry:

The drug is widely used in Ireland. These are early trial results on a very select number of patients who are high-ventilatory support and highly dependent. We have sent an alert out to our own clinical community. As with any other drug that is licensed and available, it will be based on individual clinical judgment in the appropriate critical care settings.